class action lawsuit

Picard Medical ($PMI) faces class action securities fraud suit alleging false statements, insider share dumping via offshore accounts, and social media misinformation between Sept-Oct 2025.

Robbins LLP filed securities class action against $NAVN, alleging the company concealed a 39% spike in sales and marketing expenses during its October 2025 IPO.

NuScale Power faces securities fraud lawsuit over alleged misstatements about commercialization strategy and partner qualifications, with stock dropping 14.4% after $495M and $532M loss disclosures.

Plug Power faces securities fraud class action for allegedly misrepresenting hydrogen facility capabilities and DOE funding prospects. Shareholders have until April 3, 2026 to join suit.

Franklin BSP Realty Trust faces class action lawsuit over allegedly false dividend sustainability claims, affecting investors from November 2024 through February 2026.

$CRWV faces class action suit alleging misleading statements about customer demand and vendor concentration risks. Investors who bought shares between March-December 2025 can join lawsuit.

Class action filed against $OST alleging $950M pump-and-dump scheme during May-June 2025. Investors have until April 17, 2026 to seek lead plaintiff status.

Law Offices of Frank R. Cruz files class actions against $AGHI, $FRMI, $VRNS, $ARDT for materially false statements. Lead plaintiff deadlines March 2-9, 2026.

DJS Law Group files class action against Paysafe for alleged securities violations involving misleading financial guidance and undisclosed credit risk exposure.

Schall Law Firm seeks lead plaintiffs in class action against $PSFE for allegedly misrepresenting high-risk client exposure and credit reserves.

Schall Law Firm launches class action against $ARDT for alleged false statements on receivables and insurance practices. Investor deadline: March 9, 2026.

Rosen Law Firm sues Snowflake for allegedly hiding how new products would harm consumption and revenue. Lead plaintiff deadline: April 27, 2026.

Agilon Health faces securities class action over alleged 2025 guidance misstatements. Lead plaintiff deadline is March 2, 2026 for investors with losses.

uniQure's $QURE stock crashes 49% after FDA rejects Huntington's gene therapy approval pathway; securities fraud lawsuit filed alleging misleading statements about regulatory expectations.

Class action lawsuit filed against $LAKE alleging executives made false statements about Pacific Helmets and Jolly business performance while concealing operational issues.

Class action lawsuit filed against $AMC for allegedly misleading APE preferred equity unit holders about dividend rights following August 2023 conversion to common stock.

Class action lawsuit filed against Ardent Health for alleged $57.5M EBITDA overstatement and revenue misstatements tied to new accounting systems and sector headwinds.

Class action lawsuit filed against BellRing Brands alleging materially false statements about sales performance driven by inventory buildup rather than genuine demand.

Class action filed against China Liberal Education Holdings over alleged pump-and-dump scheme; stock collapsed January 30, 2025. DOJ pursuing criminal charges.

Class action lawsuit filed against $UGXY alleging securities fraud related to setrusumab clinical trial data. Investors from August 2023 to December 2025 eligible.